Galapagos NV ADR (GLPG) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $33.49
• Market Cap: $2.26B
• EPS: $-7.98
• 52-Week High: $37.78
• 52-Week Low: $22.59

Market Sentiment

Galapagos NV ADR currently has a Bullish sentiment score of 0.27.

About Galapagos NV ADR

Galapagos NV (Ticker: GLPG) is a clinical-stage biotechnology firm based in Mechelen, Belgium, focused on discovering and developing innovative small molecule medicines for severe diseases with high unmet medical needs. The company has a robust pipeline of drug candidates, leveraging its proprietary drug discovery platform and expertise in various therapeutic areas, including immunology and inflammation. Galapagos collaborates with leading pharmaceutical companies to enhance its research capa...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Galapagos NV ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does GLPG pay dividends?

Galapagos NV ADR (GLPG) does not currently pay a regular dividend.

What is GLPG's market cap?

Galapagos NV ADR (GLPG) has a market capitalization of $2.26B with a current stock price of $33.49.